Eli Lilly and Company (LLY)
NYSE: LLY · IEX Real-Time Price · USD
820.34
+5.28 (0.65%)
At close: May 31, 2024, 4:04 PM
818.98
-1.36 (-0.17%)
After-hours: May 31, 2024, 7:59 PM EDT
Eli Lilly Market Cap
Eli Lilly has a market cap or net worth of $779.66 billion as of May 31, 2024. Its market cap has increased by 94.07% in one year.
Market Cap
779.66B
Enterprise Value
803.28B
1-Year Change
94.07%
Ranking
Category
Stock Price
$820.34
Market Cap Chart
Since December 1, 1998, Eli Lilly's market cap has increased from $99.25B to $779.66B, an increase of 685.56%. That is a compound annual growth rate of 8.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2024 | 774.64B | 0.43% |
| May 29, 2024 | 771.28B | 0.45% |
| May 28, 2024 | 767.79B | 0.05% |
| May 24, 2024 | 767.39B | -0.13% |
| May 23, 2024 | 768.36B | 0.69% |
| May 22, 2024 | 763.09B | -0.03% |
| May 21, 2024 | 763.34B | 2.55% |
| May 20, 2024 | 744.34B | 1.71% |
| May 17, 2024 | 731.81B | -0.15% |
| May 16, 2024 | 732.88B | -2.02% |
| May 15, 2024 | 747.99B | 3.02% |
| May 14, 2024 | 726.09B | 0.83% |
| May 13, 2024 | 720.12B | -0.30% |
| May 10, 2024 | 722.31B | -1.50% |
| May 9, 2024 | 733.29B | -0.45% |
| May 8, 2024 | 736.56B | -0.36% |
| May 7, 2024 | 739.20B | 1.45% |
| May 6, 2024 | 728.66B | 4.31% |
| May 3, 2024 | 698.52B | -2.77% |
| May 2, 2024 | 718.42B | -2.68% |
| May 1, 2024 | 738.23B | -0.56% |
| Apr 30, 2024 | 742.36B | 5.98% |
| Apr 29, 2024 | 700.46B | 0.50% |
| Apr 26, 2024 | 696.96B | 1.19% |
| Apr 25, 2024 | 688.75B | -1.00% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 584.00B |
| UnitedHealth Group | 446.13B |
| Johnson & Johnson | 347.62B |
| Merck & Co. | 318.88B |
| AbbVie | 273.34B |
| AstraZeneca | 235.88B |
| Thermo Fisher | 216.55B |
| Novartis AG | 194.40B |